Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of liraglutide on pancreatic hormones and pancreas size in overweight non-diabetic subjects
2016-004768-20Phase 4Completed
- Sponsor
- University of Copenhagen
- Start
- Dec 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, single-arm trial of liraglutide in Overweight, sponsored by University of Copenhagen. Primary endpoint: Pancreas volume by magnetic resonance imaging. Started Dec 2016; status: completed.
02
Drugs
03
Conditions
Overweight
Beyond the preview
Go deeper on 2016-004768-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004768-20.